Home
>
US Stocks
>
Intercept Pharmaceuticals Inc
Intercept Pharmaceuticals Inc
ICPT

Intercept Pharmaceuticals Inc (ICPT)

$16.8825.97%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
16.99
Today Low/High
16.82 / 17.56
52 Week Low/High
$13.29 / $50.75
P/E ratio
-2.6775
Market Cap
$455.52M

Company Details

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.
Organisation
Intercept Pharmaceuticals Inc
Employees
498
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Intercept Pharmaceuticals Inc (ICPT) share price today?

Can Indians buy Intercept Pharmaceuticals Inc (ICPT) shares?

How can I buy Intercept Pharmaceuticals Inc (ICPT) shares from India?

Can Fractional shares of Intercept Pharmaceuticals Inc (ICPT) be purchased?

What are the documents required to start investing in Intercept Pharmaceuticals Inc (ICPT) stocks?

We are a SEBI registered investement advisor